Your Location: Home > Products > methyl N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(phenylmethoxy)carbonyl]-L-lysinate

methyl N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(phenylmethoxy)carbonyl]-L-lysinate

  • Cas number:2389-49-3
  • purity:99%
Post inquiry

Product Details

Cost-effective and customizable methyl N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(phenylmethoxy)carbonyl]-L-lysinate 2389-49-3 factory

  • Molecular Formula: C20H30 N2 O6
  • Molecular Weight: 394.468
  • Vapor Pressure: 6.34E-12mmHg at 25°C 
  • Melting Point: 62.5-63.5 °C 
  • Boiling Point: 544.7°Cat760mmHg 
  • PKA: 10.95±0.46(Predicted) 
  • Flash Point: 283.2°C 
  • PSA: 102.96000 
  • Density: 1.13g/cm3 
  • LogP: 3.93120 

methyl N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(phenylmethoxy)carbonyl]-L-lysinate(Cas 2389-49-3) Usage

InChI:InChI=1/C20H30N2O6/c1-20(2,3)28-18(24)21-13-9-8-12-16(17(23)26-4)22-19(25)27-14-15-10-6-5-7-11-15/h5-7,10-11,16H,8-9,12-14H2,1-4H3,(H,21,24)(H,22,25)

2389-49-3 Relevant articles

Serine- and threonine-derived diamine equivalents for site-specific incorporation of platinum centers in peptides, and the anticancer potential of these conjugates

Kumbhakonam, Sateeshkumar,Vellaisamy, Kasipandi,Saroj, Soumya,Venkatesan, Nalini,Karunagaran,Manheri, Muraleedharan Kannoth

, p. 2450 - 2458 (2018/02/19)

A modular strategy that allows introduct...

Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists

-

Paragraph 0323, (2014/09/03)

The present invention relates to a conju...

Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists

-

Paragraph 0412; 0432, (2014/09/03)

A conjugated compound of Formula I: Q-Z—...

Novel compositions of TLR7 and/or TLR8 agonists conjugated to lipids

-

Paragraph 0174; 0175, (2014/01/08)

The present invention concerns a conjuga...

2389-49-3 Process route

Z-Lys(Boc)-OH
2389-60-8

Z-Lys(Boc)-OH

N<sup>α</sup>-(benzyloxycarbonyl)-N<sup>ε</sup>-(tert-butoxycarbonyl)-L-lysine methyl ester
2389-49-3

Nα -(benzyloxycarbonyl)-Nε -(tert-butoxycarbonyl)-L-lysine methyl ester

Conditions
Conditions Yield
Z-Lys(Boc)-OH; With caesium carbonate; In N,N-dimethyl-formamide; at 20 ℃; for 2h;
With methyl iodide; In N,N-dimethyl-formamide; at 20 ℃;
96%
Multi-step reaction with 2 steps
1: oxalyl chloride / CH2 Cl2 ; dimethylformamide / 1 h / 0 °C
2: CH2 Cl2 / 1 h / Ambient temperature
With oxalyl dichloride; In dichloromethane; N,N-dimethyl-formamide;
methanol
67-56-1

methanol

Z-Lys(Boc)-OH
2389-60-8

Z-Lys(Boc)-OH

N<sup>α</sup>-(benzyloxycarbonyl)-N<sup>ε</sup>-(tert-butoxycarbonyl)-L-lysine methyl ester
2389-49-3

Nα -(benzyloxycarbonyl)-Nε -(tert-butoxycarbonyl)-L-lysine methyl ester

Conditions
Conditions Yield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine; In dichloromethane; at 20 ℃; for 2h; pH=8;
99%
With dmap; dicyclohexyl-carbodiimide; Inert atmosphere;
94%
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine; In dichloromethane; at 20 ℃; for 2h; pH=8;

2389-49-3 Upstream products

  • 186581-53-3
    186581-53-3

    diazomethane

  • 2212-76-2
    2212-76-2

    Nα -benzyloxycarbonyl-Nε -tert-butyloxycarbonyl-L-lysine dicyclohexylamine salt

  • 67-56-1
    67-56-1

    methanol

  • 1070-19-5
    1070-19-5

    N-(tert-butyloxycarbonyl) azide

2389-49-3 Downstream products

  • 3017-32-1
    3017-32-1

    (S)-methyl 2-amino-6-(tert-butoxycarbonylamino)hexanoate

  • 5591-93-5
    5591-93-5

    (S)-methyl 6-amino-2-(benzyloxycarbonylamino)hexanoate

  • 122314-13-0
    122314-13-0

    tert-butyl-N-[(5S)-5-(benzyloxycarbonylamino)-6-oxo-hexyl]carbamate

  • 26348-68-5
    26348-68-5

    N-(benzyloxycarbonyl)lysine methyl ester hydrochloride

methyl N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(phenylmethoxy)carbonyl]-L-lysinate

CAS:2389-49-3

Purity:99%

Contact Now

We will contact you as soon as possible


submit